 |
PDBsum entry 6t2h
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.1.98
- [Wnt protein] O-palmitoleoyl-L-serine hydrolase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[Wnt protein]-O-(9Z)-hexadecenoyl-L-serine + H2O = [Wnt protein]-L-serine + (9Z)-hexadecenoate + H+
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
30:126751
(2020)
|
|
PubMed id:
|
|
|
|
|
| |
|
Scaffold-hopping identifies furano[2,3-d]pyrimidine amides as potent Notum inhibitors.
|
|
B.N.Atkinson,
D.Steadman,
W.Mahy,
Y.Zhao,
J.Sipthorp,
E.D.Bayle,
F.Svensson,
G.Papageorgiou,
F.Jeganathan,
S.Frew,
A.Monaghan,
M.Bictash,
E.Y.Jones,
P.V.Fish.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The carboxylesterase Notum is a key negative regulator of the Wnt signaling
pathway by mediating the depalmitoleoylation of Wnt proteins. Our objective was
to discover potent small molecule inhibitors of Notum suitable for exploring the
regulation of Wnt signaling in the central nervous system. Scaffold-hopping from
thienopyrimidine acids 1 and 2, supported by X-ray structure determination,
identified 3-methylimidazolin-4-one amides 20-24 as potent inhibitors of Notum
with activity across three orthogonal assay formats (biochemical,
extra-cellular, occupancy). A preferred example 24 demonstrated good stability
in mouse microsomes and plasma, and cell permeability in the MDCK-MDR1 assay
albeit with modest P-gp mediated efflux. Pharmacokinetic studies with 24 were
performed in vivo in mouse with single oral administration of 24 showing good
plasma exposure and reasonable CNS penetration. We propose that 24 is a new
chemical tool suitable for cellular studies to explore the fundamental biology
of Notum.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |